Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
PreemieFort Enteral Solution's approval marks the first time a nutritional product derived from human milk has been recognized as a prescription medicine anywhere in the world
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
Subject Expert Committee(SEC) of Central Drugs Standard Control Organization (CDSCO)
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
Subscribe To Our Newsletter & Stay Updated
